Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease

References

• Shanahan F. Crohn’s disease. Lancet 2002;359:60–2.
   Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411: 599–603.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411:603–6.
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001;357:1925–8.
   PubMed Web of Science ®Google Scholar
• Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993–1000.
   PubMed Web of Science ®Google Scholar
• Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003;124:1001–9.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276: 4812–8.
   PubMed Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6: 8–15.
   Google Scholar
• Ahmad T, Marshall SE, Mulcahy-Hawes K, Orchard T, Crawshaw J, Armuzzi A, et al. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 2002;60:164–79.
   Google Scholar
• Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype- phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845–7.
   PubMed Web of Science ®Google Scholar
• Radlmayr M, Torok HP, Martin K, Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn’s disease. Gastroenterology 2002;122:2091–2.
   PubMed Web of Science ®Google Scholar
• Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet 2002;359:1661–5.
   PubMed Web of Science ®Google Scholar
• Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867–74.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002;71:74–83.
   PubMed Web of Science ®Google Scholar
• Vavassori P, Borgiani P, D’Apice MR, DeNegris F, Del Vecchio Blanco G, Monteleone I, et al. 3020insC mutation within the NOD2 gene in Crohn’s disease: frequency and association with clinical pattern in an Italian population. Dig Liver Dis 2002;34: 153.
   Google Scholar
• Bonen DK, Nicolae DL, Moran T, Turkyilmaz MA, Ramos R, Karaliukas R, et al. Racial differences in NOD2 variation: characterization of NOD2 in African-Americans with Crohn’s disease. Gastroenterology 2002;122 Suppl:A29.
   Google Scholar
• Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology 2002;123:86–91.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn’s disease. J Hum Genet 2002;47: 469–72.
   Google Scholar
• Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, et al. Crohn’s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003;124:140–6.
   PubMed Web of Science ®Google Scholar
• Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001;36:2–15.
   Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;170 Suppl:2–6.
   Google Scholar
• Loftus EV, Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:1–20.
   PubMed Web of Science ®Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690–7.
   PubMed Web of Science ®Google Scholar
• Crichton D, Arnott I, Watts D, Mowat C, Hutchinson J, Drummond H, et al. NOD2/CARD15 mutations in a Scottish Crohn’s disease population. Gastroenterology 2002;122 Suppl: A298.
   Google Scholar
• Watts DA, Satsangi J. The genetic jigsaw of inflammtory bowel disease. Gut 2002;50 Suppl III:iii31–iii36.
   Google Scholar
• Murillo L, Crusius JB, van Bodegraven AA, Alizadeh BZ, Peña AS. CARD15 gene and the classification of Crohn’s disease. Immunogenetics 2002;54: 59–61.
   Google Scholar
• Annese V, Latiano A, Andreoli A, Astegiano M, Bollani B, Campieri M, et al. Mutations of NOD2 gene weakly correlate with the Vienna classification of Crohn’s disease (SD). Gastroenterology 2002;122 Suppl:A–296.
   Google Scholar
• Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn’s disease. Gastroenterology 2002; 122: 854–66.
   Google Scholar
• Zhou Z, Lin XY, Akolkar P, Gulwani-Akolkar B, Levine J. Variation at NOD2 in familial and sporadic cases of Crohn’s disease in the Ashkenazi Jewish population. Gastroenterology 2002;122 Suppl:A–296.
   Google Scholar
• Lewis JD. The genesis of IBD genetics. Gastroenterology 2002; 123:2148–9.
   PubMedGoogle Scholar
• Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777–82.
   Google Scholar
• Russel MG, Dorant E, Brummer RJ, van de Kruijs MA, Muris JW, Bergers JM, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: results of a large case- control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997;113:377–82.
   Google Scholar
• Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, et al. NOD2/CARD15 does not influence response to infliximab in Crohn’s disease. Gastroenterology 2002;123: 106–11.
   Google Scholar
• Mascheretti S, Hampe J, Croucher PJ, Nikolaus S, Andus T, Schubert S, et al. Response to infliximab treatment in Crohn’s disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics 2002;12:509–15.
   PubMedGoogle Scholar